Whitefort Capital Management, LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Whitefort Capital Management, LP disclosed 18 US equity positions worth $209.0m in its Q4 2024 13F filing. The largest position was ABUS at 20.7% of the reported book, followed by ROIV and LQDA. Against the Q3 2024 filing, it opened 1 new position, added to 3 and reduced 5 among the top 18 holdings.
What did Whitefort Capital Management, LP own in Q4 2024? Top 18 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | ABUS ARBUTUS BIOPHARMA CORP | Healthcare | 20.7% | $43.3m | 13,241,916 | 3% | added |
| 2 | ROIV ROIVANT SCIENCES LTD | Healthcare | 13.5% | $28.3m | 2,391,000 | 0% | held |
| 3 | LQDA LIQUIDIA CORPORATION | Healthcare | 11.2% | $23.4m | 1,987,245 | 17% | added |
| 4 | GNW GENWORTH FINL INC | Financial Services | 10.0% | $20.9m | 2,986,960 | 0% | held |
| 5 | CDZI CADIZ INC | 9.3% | $19.3m | 3,719,951 | – | new | |
| 6 | JOYY JOYY INC | Communication Services | 8.4% | $17.6m | 420,427 | -26% | reduced |
| 7 | 0C3 ENDEAVOR GROUP HLDGS INC | 7.5% | $15.6m | 500,000 | -50% | reduced | |
| 8 | NN NEXTNAV INC | 4.7% | $9.8m | 629,590 | -50% | reduced | |
| 9 | GLOBAL SHIP LEASE INC NEW | 3.9% | $8.1m | 369,768 | 1% | added | |
| 10 | ESPERION THERPEUTICS INC NE | 3.7% | $7.8m | 8,000,000 | 0% | held | |
| 11 | SABRE GLBL INC | 2.4% | $4.9m | 5,000,000 | 0% | held | |
| 12 | INNOVATE CORP | 2.0% | $4.2m | 12,218,000 | 0% | held | |
| 13 | MAIDEN HOLDINGS LTD | 1.6% | $3.4m | 1,997,005 | -2% | reduced | |
| 14 | VATE INNOVATE CORP | 0.8% | $1.6m | 320,131 | 0% | held | |
| 15 | NEXTNAV INC | 0.3% | $579.1k | 100,880 | -79% | reduced | |
| 16 | OPK OPKO HEALTH INC | Healthcare | 0.1% | $197.7k | 134,490 | 0% | held |
| 17 | TRIB TRINITY BIOTECH PLC | 0.0% | $72.1k | 81,902 | 0% | held | |
| 18 | ALTENERGY ACQUISITION CORP | 0.0% | $783 | 186,315 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.